Contact Us Contact Us Contact Us

Updated July 2026

Pharma Guide · Buyer Checklist

6 Things to Check Before Choosing a WHO-GMP Certified Pharma Company in India

India has over 500 WHO-GMP certified pharmaceutical facilities (CDSCO, 2024-25) — but the vast majority are either large regulated-market companies inaccessible to small-to-medium buyers, or single-dosage-form manufacturers with limited range. Six specific checks help you find one that is both genuinely WHO-GMP certified and actually accessible to a programme your size.

  • 10 companies reviewed
  • WHO-GMP verified criteria
  • 14 min read

  • WHO-GMP Status

    Active cert — not expired

  • Sample COA

    real batch data, 24 hours

  • DCGI Approvals

    molecule-level approval

  • COPP on file

    for your target country

  • Grade A/B cleanroom

    sterile injectable

  • Written by

    Bhavya Bhambani

    Content Writer, 9M India

  • Reviewed by

    Manish Agrawal

    MD, 9M India Limited

  • Fact-checked by

    Manish Shah

    Plant Head, 9M India

About 9M India Limited — examples and standards referenced in this guide

9M India Limited is a WHO-GMP certified pharmaceutical manufacturer established in 2009, located in Birkoni, District Mahasamund, Chhattisgarh. Unlike many of India’s largest WHO-GMP certified companies, which are structured around domestic branded sales or large regulated-market export, 9M India is deliberately structured to engage small-to-medium international buyers at 1–10 lakh unit MOQs. This guide uses 9M India’s documentation standards as the benchmark — COPP, FSC, COA, and stability data available within 24 hours, exports to 15+ countries.

Why these 6 checks matter — industry context

India has over 500 WHO-GMP certified pharmaceutical manufacturing facilities as of the most recent CDSCO data (2024-25). A verification challenge specific to this category: many of India’s largest WHO-GMP certified companies are structured around either domestic branded sales through extensive field forces, or large regulated-market (US/EU) generic export with multi-million-unit minimum batch sizes — neither commercial model accommodates a buyer sourcing 1–5 lakh units for Africa or Middle East markets. Finding a company that is both genuinely certified and genuinely accessible requires checking accessibility explicitly, not assuming it from certification status alone.

WHO-GMP Verification

Verify the WHO-GMP certificate directly — issue date, expiry, and scope

Request the actual certificate PDF rather than accepting a website claim.

#1 of 6

Request the actual CDSCO-issued WHO-GMP certificate PDF and check the issue date, expiry, and the specific scope of dosage forms covered. A company “WHO-GMP certified” for one product line may not hold that certification for the dosage form you actually need.

What is WHO-GMP certification in India?
WHO-GMP is a pharmaceutical-specific manufacturing standard covering facility design, cleanroom classification, water systems, air handling, process validation, analytical QC, and batch documentation, issued by CDSCO following facility inspection. It is time-limited and requires periodic re-inspection to remain valid.

How to verify - step by step

  • Request the actual certificate document: Not a website badge or verbal assurance — the CDSCO-issued PDF.

  • Check the issue date and expiry explicitly: Certificates are time-limited and require periodic re-inspection.

  • Check the scope line for your specific dosage form: Coverage doesn’t automatically extend across all dosage forms.

  • Cross-verify on the CDSCO database: At cdsco.gov.in using the company’s licence number.

Why this check matters for export
Import regulatory authorities require the submitted certificate to be currently valid and to explicitly cover the dosage form being registered — a general claim of “WHO-GMP certified” without the actual certificate is not sufficient for dossier submission.

Red flags to watch for

Company cites WHO-GMP without providing the actual certificate · Certificate scope doesn’t cover your required dosage form · Certificate older than 3 years without re-inspection documentation · Cannot provide certificate within 24 hours

From Industry Rankings

See how the top 10 WHO-GMP certified pharma companies in India compare on buyer accessibility

Our editorial ranking compares the top 10 WHO-GMP certified pharma companies in India across all 6 criteria in this guide — certification scope, accessibility for small-medium buyers, DCGI approvals, documentation speed, COA completeness, and export track record.

See the full ranking

Buyer Accessibility

Confirm accessibility for your programme size, not just large-buyer accessibility

Many of India's largest WHO-GMP certified companies won't engage a 1–5 lakh unit buyer at all — confirm this before investing time.

#2 of 6

Many of India’s largest WHO-GMP certified companies are structured around domestic branded sales or large regulated-market export, with commercial minimums and sales processes that don’t accommodate small-to-medium international buyers. Confirm directly that the company engages with buyers at your realistic order volume before investing significant time in the relationship.

Why this check matters more than certification status alone
A company’s WHO-GMP certification tells you they’re capable of quality manufacturing — it tells you nothing about whether they’ll actually engage commercially with a buyer at your scale. This is a distinct, practical question worth asking directly and early.

How to verify — step by step

  • State your realistic order volume in your first enquiry: Don’t wait to be asked — this filters for genuine accessibility quickly.

  • Ask directly if they engage with buyers at your programme size: A clear, direct answer here is itself informative.

  • Notice response speed and tone to a small-medium enquiry: Companies genuinely structured for this segment respond promptly and specifically

  • Ask what their typical buyer profile looks like: This reveals whether your programme size is a fit or an outlier for them.

Why this check matters for export
Time invested pursuing a relationship with a company that ultimately won’t engage at your volume is time not spent on a genuinely accessible manufacturer — asking this question first protects your timeline.

Red flags to watch for

No response, or generic non-specific response, to a clearly stated small-medium volume enquiry · Sales process clearly built around large distributor or institutional buyers only · Pricing/MOQ structure doesn’t accommodate your stated volume at all · Company redirects you to a much larger minimum without discussion

DCGI Approval

Confirm DCGI approval at the molecule level for your specific requirement

WHO-GMP certifies the facility; DCGI approval authorises each specific molecule and dosage form.

#3 of 6

WHO-GMP certifies the facility as a whole. DCGI manufacturing approval is molecule and dosage-form specific. Confirm both are in place for your exact requirement before proceeding — a company can be genuinely WHO-GMP certified and still lack approval for your specific product.

Why this two-layer verification matters
This distinction — facility-level certification versus product-level approval — is the single most common source of confusion for buyers new to sourcing from India. Both must be verified separately, and neither substitutes for the other.

How to verify — step by step

  • Request the DCGI manufacturing licence for your exact molecule: Strength and dosage-form specific.

  • Confirm this is separate from, and in addition to, the WHO-GMP certificate: Both documents should exist independently

  • Check the approval is currently active: Not expired or pending renewal.

  • Verify against your exact specification: Not a similar molecule or a different strength.

Why this check matters for export

Import regulators require the dossier to cite a valid, product-specific manufacturing licence — not just a facility-level WHO-GMP certificate. Both documents are typically requested as part of a complete registration submission.

Red flags to watch for

Company presents WHO-GMP certificate as if it also confirms product-specific approval · DCGI licence doesn’t match your exact molecule or strength · Approval status unclear or pending · Confusion between facility and product-level documentation when asked directly

From the Compare section

WHO-GMP vs ISO 9001 — which certification actually matters when sourcing from India?

Eight in ten pharma companies in India hold ISO 9001. Fewer than two in ten hold active WHO-GMP from CDSCO. For drug registration with NAFDAC, MOH UAE, PPB, or SFDA, WHO-GMP is mandatory — ISO 9001 is not accepted as an equivalent by any pharmaceutical regulatory authority.

Complete COA
WHO-GMP certified facility

Sterility · Bacterial endotoxin · Particulate matter · Assay · pH — all required and documented per WHO-GMP batch release procedure.

  • All tests mandatory for batch release
ISO 9001 only facility

Sterility · Bacterial endotoxin · Particulate matter · Assay · pH — all required and documented per WHO-GMP batch release procedure.

  • Pharma-specific tests not mandated
Read Full Comparison

Certificate of Analysis

Request a sample Certificate of Analysis — available within 24 hours

A genuinely production-ready, commercially active company holds batch data on file and responds fast.

#4 of 6

A genuinely production-ready, commercially active WHO-GMP company holds batch data on file and should provide a sample Certificate of Analysis within 24 hours. Slow or incomplete responses here often indicate the molecule isn’t in active commercial production, regardless of what the product catalogue shows.

What a complete COA reveals about a company’s actual operational status
A company’s product catalogue often lists far more molecules than are genuinely in regular commercial production. Requesting a sample COA is the fastest practical way to distinguish an actively-produced molecule from one that’s technically approved but not currently manufactured at scale.

How to verify — step by step

  • Request a real sample COA for your specific molecule: From an actual recent batch, not a generic template.

  • Time the response: 24 hours is the benchmark for a genuinely production-ready company.

  • Check for complete numerical results: Not just pass/fail statements.

  • Verify the signing authority: Should be signed by a Qualified Person or pharmacist.

Why this check matters for export
International regulators require actual numerical results, not just pass/fail — a COA that arrives quickly and complete is a strong signal of genuine, ongoing production discipline.

Red Flags to Watch For

COA not available within 24 hours · COA is a blank template without real batch data · Company claims the molecule is “in the catalogue” but can’t produce recent batch data · COA shows only pass/fail without numerical results

Export References

Ask for export references and COPP in your specific target country

An existing COPP for your target market shortens registration timelines by 6–12 months.

#5 of 6

An existing Certificate of Pharmaceutical Product for your target market shortens registration timelines by 6–12 months. Ask directly whether the company has previously registered products with a regulatory authority similar to yours.

What is a COPP (Certificate of Pharmaceutical Product)?
A COPP is issued under the WHO Certification Scheme by CDSCO for products manufactured by a DCGI-licensed manufacturer at a WHO-GMP certified facility. For buyers targeting government procurement or NHM-type programmes, ask specifically whether the company has supplied similar programmes before — this experience often signals stronger documentation discipline overall. (WHO Technical Report Series No. 986, Annex 10)

How to verify — step by step

  • Ask “Have you previously exported to [country]?” — request the specific product name and year of first registration.

  • Ask “Do you hold an active COPP for [country]?” — confirm it covers your exact molecule and dosage form.

  • Ask “Can you provide a CTD or ACTD dossier?” — export-experienced companies typically hold ready dossiers.

  • Ask about government procurement or institutional supply experience if relevant: This often signals stronger documentation and quality discipline.

Why this check matters for export
Dossier review queues in Africa and the Middle East are long; an existing COPP eliminates the initial 30–90 day waiting period entirely.

Red Flags To Watch For

Vague answers about prior export experience · COPP offered doesn’t match your specific molecule · No CTD/ACTD dossier despite claimed export history · Cannot name a specific country or product previously registered

Documentation Speed

Test documentation turnaround time — the fastest way to separate real capability from marketing claims

Send a direct documentation request and time the response.

#6 of 6

Send a direct documentation request and time the response. Companies that are commercially serious about export and genuinely production-ready respond within 24 hours; slower responses often reveal gaps between marketing claims and operational reality.

Why this is the single fastest verification method in this entire guide
Every other check in this guide requires evaluating a document once received. This check evaluates the company’s actual operational discipline in real time — and takes less effort than any other verification step while revealing perhaps the most about whether the relationship will work long-term.

How to verify — step by step

  • Send a documentation request specifying your exact molecule: WHO-GMP certificate, DCGI approval confirmation, sample COA.

  • Note the time sent and time of response: 24 hours is the stated benchmark for genuinely ready companies.

  • Follow up requesting COPP and stability data: Should arrive within 24-48 hours for existing export products.

  • Treat the entire exchange as representative of future interactions: Not a one-time test, but a preview of the ongoing relationship.

Why this check matters for export
A company slow to provide basic documentation before any commitment has been made is unlikely to become faster once a purchase order and ongoing relationship are in place — this is a preview, not an exception.

Red Flags To Watch For
No response within 48 hours to a documentation request · Documents arrive incomplete or as generic templates · Company asks for a purchase order before providing any documentation · Multiple follow-ups required to get a straight answer

More Pharma Guide

Frequently asked questions

  • How many WHO-GMP certified pharma companies are there in India?

    India has over 500 WHO-GMP certified pharmaceutical manufacturing facilities as of the most recent CDSCO data. However, a large proportion are single-dosage-form specialists or large companies focused on domestic and regulated-market business, not necessarily accessible to small-to-medium international export buyers.

    Reference: CDSCO Annual Report, 2024-25

  • How is WHO-GMP different from ISO 9001 certification?

    WHO-GMP is a pharmaceutical-specific manufacturing standard covering cleanroom classification, water systems, process validation, and batch documentation, issued by CDSCO following facility inspection. ISO 9001 is a general quality-management standard not accepted for pharmaceutical drug registration.

  • Why do many WHO-GMP certified companies not work with small-to-medium buyers?

    Many of India’s largest WHO-GMP certified companies are structured around domestic branded sales through extensive field forces, or large regulated-market (US/EU) generic export with multi-million-unit minimum batch sizes — neither model accommodates a buyer sourcing 1–5 lakh units for Africa or Middle East markets.

  • What should I ask first when evaluating a WHO-GMP certified company?

    State your realistic order volume in your very first enquiry, and ask directly whether they engage with buyers at that scale. This single question filters accessibility faster than any document review.

    British Pharmacopoeia 2024

  • What documents does a WHO-GMP certified company provide for export?

    WHO-GMP Certificate, DCGI Manufacturing Licence for the specific molecule, COPP from CDSCO, Free Sale Certificate, COA per batch, ICH Zone IVb stability data, and a CTD/ACTD Dossier for registration submission.

9M India — passes all 6 checks

Ready to verify 9M India against your checklist?

WHO-GMP certificate, DCGI approval, sample COA, COPP, stability data — all available within 24 hours of your first enquiry.

Send an enquiry
WHO-GMP
WhatsApp

WHO-GMP certified · DCGI approved · 15+ export countries · Birkoni, Chhattisgarh · Est. 2009

By Formulation Type
Tablets Capsules Granules & Powders Syrups Suspensions Solutions Ointments Creams Gels Injections Eye Drops Ear Drops External Liquid Dosage
By Therapeutic Segment
Antibiotics Pain Management Cardiovascular Diabetic Care CNS / Neurology Gastrointestinal Respiratory Dermatology Vitamins & Minerals Ophthalmic Paediatrics Anti Infective

Looking for something specific?

At 9M India Limited, trust through quality, transparency, performance.

Get In Touch With Us

Contract Manufacturing

Contract Manufacturing

3rd Party Manufacturing

3rd Party Manufacturing

Institutional Tenders

Institutional Tenders

Generic Medicines

Generic Medicines

OTC Products

OTC Products

Regulatory Services

QC & QA